About Thomas McDonald
Form D filings for Diasome Pharmaceuticals from 2017 to 2024 list Thomas McDonald as director.
Thomas McDonald first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas McDonald in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas McDonald works with at each company, as listed on that company's latest Form D.
Diasome Pharmaceuticals, Inc. · Form D, Aug 15, 2024
PT
Peter Tollman
Director
RG
Robert Geho
Chief Executive Officer and director
FM
Frank McCaney
Director
WG
W. Geho
Executive officer and director
CO
Cosme Ordonez
Director